DOC Generici

Row of test tubes with liquid, pink background


Direct investment

Transaction completed in Q4 FY23

Key Stats

  • ~€11m investment in 2019, originated and managed by ICG
  • Realisation in the final quarter of the financial year to 31 January 2023 (FY23)
  • Sale generated proceeds of £24.3m in FY23
DOC Generici is a leading manufacturer of generic pharmaceuticals based in Italy

Differentiated business model

Consolidated network of suppliers, mainly in Europe and China, to maintain an asset light business model.

Structural growth drivers

Growing health & wellness market increasing health awareness among consumers, underpinned by structural demographic drivers from an aging population.

Dominant market position

Leading manufacturer in a concentrated and heavily regulated market with high barriers to entry.

Track record

Management team with over 20 years sector experience and a successful previous buy-out track record.